Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 2012-2020
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.2012
Table 1 Gastric mesenchymal and smooth muscle tumours on plain gastroscopy and endoscopic ultrasound
Clinical parameters
Intragastric mesenchymal tumour
Smooth muscle tumour
Male24 (48.0)22 (44.0)
Female26 (52.0)28 (56.0)
Age, yr50.5 ± 14.0a57.9 ± 9.5
Location, %
Cardia01 (2.0)
Gastric base26 (52.0)12 (24.0)
Gastric body18 (36.0)11 (22.0)
Gastric sinus9 (18.0)2 (4.0)
Diameter, mm16.2 ± 9.9a9.7 ± 5.0
Level of origin, %
Mucosal muscle layer2 (3.8)1 (2.0)
Inherent muscle layer48 (96.0)25 (50.0)
Indicated ulcers, %
Yes6 (12.0)2 (4.0)
None47 (94.0)24 (48.0)
Echo characteristics, %
Low echo50 (100)47 (94.0)
Waiting for an echo01 (2.0)
High echo0
Echo uniformity, %
Uniformity25 (49.1)a50 (100)
Non-homogeneous27 (50.0)a0
Table 2 Comparison of tumour marker levels among the three groups (mean ± SD)
Group
n
CEA (ng/mL)
CA19-9 (ng/mL)
CA-125 (kU/L)
AFP (ng/mL)
CYFRA21-1 (U/mL)
Gastric mesenchymal tumour group501.53 ± 0.249.32 ± 2.1844.34 ± 10.675.46 ± 1.188.17 ± 1.57
Gastric smooth muscle tumour group500.67 ± 0.15a8.37 ± 1.81a41.56 ± 8.745.03 ± 0.867.44 ± 1.69
Control group501.04 ± 0.18a,b6.45 ± 1.39a,b39.67 ± 7.985.29 ± 0.747.67 ± 1.88
F value198.50725.7532.6082.1001.888
P value0.0000.0000.0780.1270.156
Table 3 Receiver operating characteristic curve analysis of carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the diagnosis of gastric mesenchymal tumour
Indicators
Area under the curve
Standard error
P value
95%CI
Optimal cut-off value
Sensitivity
Specificity
CEA0.8790.0360.0000.808-0.9501.1450.8500.675
CA19-90.7820.0500.0000.684-0.8808.8800.6000.800